CIK 0001936258 · Large accelerated filer
NewAmsterdam Pharma Co N.V.
Sign in to watch- Ticker
- NAMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- operating
- Phone
- 35 206 2971
- Business address
- GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
- Former names
- NewAmsterdam Pharma Co B.V.
Securities
- NAMS Ordinary Shares Nasdaq
- NAMSW Warrant Nasdaq
- 4 Planned sale Chief Executive Officer sold 11,582 shares
- 4 Grant or award Director acquired 3,400 shares (grant or award)
- 4 Grant or award Director acquired 3,400 shares (grant or award)
- 4 Grant or award Director acquired 3,400 shares (grant or award)
- 4 Grant or award Director acquired 3,400 shares (grant or award)
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Planned sale Chief Scientific Officer sold 6,000 shares at $33.25 ($199,500)
- 4 Planned sale Chief Accounting Officer sold 2,647 shares at $33.25 ($88,013)
- 4 Planned sale Chief Financial Officer sold 5,118 shares at $33.25 ($170,174)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Accounting Officer sold 145,000 shares at an average $35.84 ($5,196,741)
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 4 of 21 · 415 filings